DePuy Synthes was awarded a contract from the U.S. Department of Defense to supply up to US $260MM worth of orthopaedic products to global U.S. military medical facilities.
Episurf Medical commenced internal actions to select its regulatory pathway for application for U.S. market acceptance. A decision is expected by 3Q17.
OrthAlign received Japan regulatory approval to market Direct Anterior HipAlign® for use in supine position THA and UniAlign™ for UKA, to be distributed by Zimmer Biomet Japan.
Providence Medical Technology closed a US $10.5MM debt agreement that will support distribution of cervical fusion technology in U.S. and ex-U.S. markets.
Vericel entered into a license agreement whereby Innovative Cellular Therapeutics will obtain exclusive rights to develop and distribute Carticel® and MACI® in Southeast Asia.